Alternate-day alternating monotherapy (q48h) versus daily concomitant atorvastatin–fenofibrate in adults with type 2 diabetes and mixed dyslipidemia: a 12-week randomized non-inferiority trial
Iranian Registry of Clinical Trials (IRCT): IRCT20250718066536N1. Registered retrospectively on 18 July 2025. Patient enrolment occurred from August 2024 to June 2025. The protocol and the primary/secondary endpoints were finalized prior to data analysis.
Authors
- Soheil Shahramirad (ORCID: https://orcid.org/0009-0005-0555-2466)
- Mohammadreza Vataniman
- Roya Jahanbazi
- Milad Rezvani
- Nasrin Razavianzadeh
Institutions
- University of Shahrood (IR)
- Islamic Azad University, Shahrood (IR)
- Hormozgan University of Medical Sciences (IR)
- Islamic Azad University, Yazd (IR)
Publication Details
- Journal
- BMC Endocrine Disorders
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1186/s12902-025-02156-z
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00